Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
BIOSIG TECHNOLOGIES INC (BSGM) Stock Price & Overview
NASDAQ:BSGM • US09073N3008
Current stock price
6.1 USD
+1.65 (+37.08%)
At close:
6.4001 USD
+0.3 (+4.92%)
After Hours:
The current stock price of BSGM is 6.1 USD. Today BSGM is up by 37.08%. In the past month the price increased by 32.61%. In the past year, price increased by 256.73%.
BSGM Key Statistics
52-Week Range0.4 - 14.11
Current BSGM stock price positioned within its 52-week range.
1-Month Range3.83 - 6.12
Current BSGM stock price positioned within its 1-month range.
- Market Cap
- 880.474M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.81
- Dividend Yield
- N/A
BSGM Stock Performance
Today
+37.08%
1 Week
+33.48%
1 Month
+32.61%
3 Months
-4.54%
Longer-term
6 Months +894.30%
1 Year +256.73%
2 Years -51.20%
3 Years -7.29%
5 Years -91.53%
10 Years N/A
BSGM Stock Chart
BSGM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BSGM. When comparing the yearly performance of all stocks, BSGM is one of the better performing stocks in the market, outperforming 97.09% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
BSGM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BSGM. BSGM has a bad profitability rating. Also its financial health evaluation is rather negative.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BSGM Earnings
Next Earnings DateNov 12, 2025
Last Earnings DateAug 12, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
BSGM Forecast & Estimates
7 analysts have analysed BSGM and the average price target is 10.2 USD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 6.1.
Analysts
Analysts82.86
Price Target10.2 (67.21%)
EPS Next Y68.52%
Revenue Next YearN/A
BSGM Financial Highlights
Over the last trailing twelve months BSGM reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS increased by 80.81% compared to the year before.
Income Statements
Revenue(TTM)10.00K
Net Income(TTM)-25.87M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.52% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%-136.67%
Sales Q2Q%-100%
EPS 1Y (TTM)80.81%
Revenue 1Y (TTM)-72.97%
BSGM Ownership
Ownership
Inst OwnersN/A
Shares144.34M
Float25.09M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
BSGM Industry Overview
BSGM operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
62/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
11%
Outperformed 11% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 3.9%
- New Lows
- 10.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.2%
- Average Operating Margin
- 22.4%
- Average P/E
- 28.9
- Average Fwd P/E
- 24.6
- Average Debt/Equity
- 0.5
BSGM Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 38.7 | 165.737B | ||
| ABT | ABBOTT LABORATORIES | 14.72 | 163.098B | ||
| SYK | STRYKER CORP | 20.75 | 123.101B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.47 | 86.867B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.02 | 47.438B | ||
| IDXX | IDEXX LABORATORIES INC | 37.29 | 45.134B | ||
| BDX | BECTON DICKINSON AND CO | 10.75 | 42.574B | ||
| RMD | RESMED INC | 17.42 | 31.633B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 11.5 | 31.256B | ||
| DXCM | DEXCOM INC | 22.85 | 22.83B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.63 | 16.028B | ||
| PEN | PENUMBRA INC | 63.83 | 12.818B | ||
| PODD | INSULET CORP | 27.62 | 12.666B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BSGM
Company Profile
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 5 full-time employees. The company went IPO on 2014-09-22. The firm has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.
Company Info
IPO: 2014-09-22
BIOSIG TECHNOLOGIES INC
55 Greens Farms Road
Westport CONNECTICUT 06880 US
CEO: Kenneth L. Londoner
Employees: 5
Phone: 12034095444
BIOSIG TECHNOLOGIES INC / BSGM FAQ
What does BIOSIG TECHNOLOGIES INC do?
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 5 full-time employees. The company went IPO on 2014-09-22. The firm has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.
Can you provide the latest stock price for BIOSIG TECHNOLOGIES INC?
The current stock price of BSGM is 6.1 USD. The price increased by 37.08% in the last trading session.
Does BIOSIG TECHNOLOGIES INC pay dividends?
BSGM does not pay a dividend.
What is the ChartMill technical and fundamental rating of BSGM stock?
BSGM has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for BSGM stock?
7 analysts have analysed BSGM and the average price target is 10.2 USD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 6.1.
Can you provide the number of employees for BIOSIG TECHNOLOGIES INC?
BIOSIG TECHNOLOGIES INC (BSGM) currently has 5 employees.